Created in 2013 (France), XANGIUS own 306 sister brands and 4958 competing brands. The XANGIUS brand is owned by Ipsen, a company listed in Paris. Its International Securities Identification Number (ISIN) is FR0010259150. XANGIUS belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
Ipsen
(XANGIUS)
over 5 years*
EUR 122.43